Brand Name: Carise Pharmaceuticals Industry / Business Category: Healthcare Products / Pharmaceutical & Nutraceutical Distribution Founded Year: 2017 Franchise Started Year: Not specified Total Franchise Outlets: 50–100 Estimated Investment: INR 50,000 – 2,00,000 Franchise Fee: Not specified Royalty Fee: Not specified Space Requirement: 100–200 sq.ft Staff Requirement: Small teams including sales and distribution personnel Expected Payback Period: 1–2 years
Carise Pharmaceuticals is a pharmaceutical and nutraceutical company focused on developing and distributing healthcare formulations across multiple therapeutic and wellness categories. It operates in the healthcare products sector, serving patients, healthcare providers, and distribution partners with medicines and nutritional supplements.
The business operates through product distribution and marketing of pharmaceutical and nutraceutical formulations. Franchise partners or distributors engage with healthcare professionals, pharmacies, and institutions to supply products. Revenue is generated through product sales across prescription medicines and wellness supplements.
Franchise partners operate as local distributors and promoters of Carise Pharmaceuticals products. Responsibilities include building relationships with doctors, pharmacies, and healthcare providers, managing inventory, and ensuring product availability in the local market. The franchisor provides product supply, portfolio access, and operational guidance.
Franchisees receive support in product knowledge, market positioning, and distribution strategies. Guidance is provided on engaging healthcare professionals, managing supply chains, and maintaining compliance with healthcare standards.
Revenue is generated through the sale of pharmaceutical and nutraceutical products to healthcare providers and retail channels. Demand is driven by ongoing healthcare needs and repeat consumption. ROI depends on distribution reach, product adoption, and relationship building with medical professionals. Expected payback period is 1–2 years.
Carise Pharmaceuticals was established in 2017 and has expanded its presence through a network of 50–100 franchise or distribution partners. The company continues to grow by expanding its product portfolio and entering new markets.
The investment ranges from INR 50,000 to 2,00,000, primarily covering inventory purchase, distribution setup, and operational costs.
Franchisees operate as local distributors, supplying pharmaceutical and nutraceutical products to healthcare providers and retail outlets while managing sales and relationships.
A compact space of 100–200 sq.ft is sufficient for storing products and handling administrative tasks.
The expected payback period is 1–2 years, depending on product demand, distribution network, and sales performance.
Investors can connect with the company’s partnership team to receive onboarding guidance, product training, and support for starting distribution operations.